Nuclear Medicine/Radiopharmaceuticals Market to Reach US$ 6,683.99 Mn at CAGR of 6.2% in 2027 | The Insight Partners

Nuclear Medicine/Radiopharmaceuticals Market to 2027 - Global Analysis and Forecasts by Applications (Diagnostic Applications, Therapeutic Applications); End User (Hospitals, Diagnostic Centers) and Geography

Publication Month: Jun 2019 | Report Code: TIPRE00003751 | No. of Pages: 185 | Category: Pharmaceuticals | Status: Published

The global nuclear medicine/radiopharmaceuticals market expected to be US$ 3,982.11 Mn in 2018 and is predicted to grow at a CAGR of 6.2% during the forecast period 2019 - 2027, to reach US$ 6,683.99 Mn by 2027.

Europe is the second largest geographic market and is expected to be the second most significant revenue contributor throughout the forecast period. The region has witnessed several technological advancements in the field of healthcare by the incorporation of advanced nuclear medicines in order to increase the efficiency of imaging processes in the region. The growth is driven by factors such as the rising prevalence of neurologic disorders such as, Alzheimer’s and others along as well as the rising focus by market players in the European countries.

Exhibit: Nuclear Medicine/Radiopharmaceuticals Lucrative Regional Markets

Market Insights

Rising Prevalence of Chronic Diseases

The chronic diseases such as heart diseases, cancer, chronic lung diseases, stroke, Alzheimer’s disease, and chronic kidney disease and other neurological disorders are growing at a rapid rate across the globe. These chronic diseases are the leading cause of deaths. According to the recent statistics of World Health Organization for the year 2019, states that chronic disease contributes approximately 60% of all deaths and 43% of the global burden of disease. It is also expected that by 2020 the incidences of deaths will rise approximately to 73% and the global burden of disease is expected to grow by 60%.

According to the World Health Organization in 2018, cancer was the second leading cause of death across the globe, and is responsible for an estimated 9.6 million deaths in 2018. Furthermore, the American Cancer Society estimated that in 2018, approximately 1,735,350 new cancer cases were diagnosed.

These chronic diseases need to be examined before the further treatment starts. And the nuclear medicines are used for the diagnosis and examination purposes. Nuclear medicines in PET and SPECT are used for the therapeutic and diagnostic purposes. Thus, owing to the increasing incidences of chronic diseases poses several opportunities for the nuclear medicine/radiopharmaceuticals market to grow during the forecast period.

 

Alpha Radioimmunotherapy-Based Targeted Oncology Treatment

Targeted alpha therapy (TAT) is a latest and evolving option for local and systemic cancer treatment. Preclinical research and clinical trials prove that alpha-emitting radionuclides kill targeted cancer cells and does not harm the normal cells, hence it reduces the toxicity. The alpha emitting radioisotopes 211At, 213Bi, 225Ac and 227Th are being used to label targeting vectors such as monoclonal antibodies for specific cancer therapy indications.

The nuclear imaging uses long lived gamma emitters, which allow blood clearance as the tumor increases its uptake of the conjugate over time, so improving contrast. The nuclear imaging agents allows dose to the tumor and organs to be determined. The high energy gamma rays are emitted from alpha emitters, which also allow dose estimates for organs and tumors. In addition, the rise in the awareness about the alpha radio immunotherapy and availability of the therapies for the cancer treatment procedures are likely to foster the demand for nuclear imaging. Thus, owing to these factors the market for the nuclear medicine/radiopharmaceuticals is likely to propel at a significant rate during the forecast period.
 

Application Insights

The global nuclear medicine/radiopharmaceuticals market by application was led by diagnostic applications segment. In 2018, the diagnostic applications segment held a largest market share of the nuclear medicine/radiopharmaceuticals market, by applications. This segment is also expected to dominate the market in 2027 owing to availability of diagnostic devices and ease offered by these devices for diagnosis of various disorders. Moreover, increasing incidences of cardiac diseases, cancer, and neurological disorders are expected to fuel the demand for better diagnosis of these disorders.


Exhibit: Nuclear Medicine/Radiopharmaceuticals Market, by Application

End User Insights

The global nuclear medicine/radiopharmaceuticals market by end user segment was led by hospitals segment. In 2018, the hospitals settings segment with a significant share in the nuclear medicine/radiopharmaceuticals market, by end user. This segment is also expected to dominate the market in 2027 owing to presence of skilled professionals in hospitals, increasing preference for better healthcare facilities as well as availability of reimbursement policies.

 

Exhibit: Nuclear Medicine/Radiopharmaceuticals Market, by End User

Strategic Insights

There have been limited developments made in the nuclear medicine/radiopharmaceuticals market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of nuclear medicine/radiopharmaceuticals. For instance, during February 2019, Advanced Accelerator Applications S.A. (AAA), a Novartis company received Health Canada approval for its Lutathera for the treatment of metastatic, well-differentiated, somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adults with progressive disease. Also, during November 2017, Cardinal Health and Shanghai Pharmaceuticals Holding Co., Ltd. signed an agreement to sell its China Business.

 

NUCLEAR MEDICINE/RADIOPHARMACEUTICALS – MARKET SEGMENTATION

 

By Application

  • Diagnostic Applications
    • SPECT (Single-Photon Emission Computed Tomography) Applications
    • PET (Positron Emission Tomography) Applications
  • Therapeutic Applications
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Therapeutic Applications 

By End User

  • Hospitals
  • Diagnostic Centers

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina 

Company Profiles

  • Cardinal Health
  • IBA Worldwide
  • Curium
  • GENERAL ELECTRIC
  • Bayer AG
  • Positron Corporation
  • NTP Radioisotopes SOC Ltd.
  • Bracco
  • Lantheus Medical Imaging Inc.
  • Advanced Accelerator Applications

1.             INTRODUCTION

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       market segmentation

1.3.1        Global Nuclear Medicine/Radiopharmaceuticals Market – By Applications

1.3.2        Global Nuclear Medicine/Radiopharmaceuticals Market – By End User

1.3.3        Global Nuclear Medicine/Radiopharmaceuticals Market – By Geography

2.             Global Nuclear Medicine/Radiopharmaceuticals Market –  Key takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Nuclear Medicine/Radiopharmaceuticals market –  market landscape

4.1       overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

5.             Global Nuclear Medicine/Radiopharmaceuticals market –  Key INDUSTRY Dynamics

5.1       Key Market Drivers

5.1.1        Rising Prevalence of Chronic Diseases

5.1.2        Alpha Radioimmunotherapy-Based Targeted Oncology Treatment

5.1.3        Advancement in Imaging Technologies using Radiopharmaceuticals

5.2       Key Market Restraints

5.2.1        Short Shelf-Life of Radiopharmaceuticals

5.2.2        Availability of Substitutes of Radiopharmaceuticals

5.3       Key Market Opportunities

5.3.1        Development in the Healthcare Market

5.3.2        High Market Potential in Emerging Nations

5.4       CURRENT TREND

5.4.1        Use of Nuclear Medicine For Personalized Treatment

5.5       IMPACT analysis

6.             Nuclear Medicine/Radiopharmaceuticals market – Global Analysis

6.1       global Nuclear Medicine/Radiopharmaceuticals market Revenue Forecasts and Analysis

6.2       global Nuclear Medicine/Radiopharmaceuticals market, By Geography - Forecasts and Analysis

6.3       PERFORMANCE/ Positioning OF KEY PLAYERS

6.3.1        Cardinal Health

6.3.2        GENERAL ELECTRIC

7.             Global Nuclear Medicine/Radiopharmaceuticals Market analysis– by applications

7.1       overview

7.2       Global Nuclear Medicine/Radiopharmaceuticals Market BY applications, 2018 & 2027 (%)

7.3       diagnostic applications Market

7.3.1        Overview

7.3.2        Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3        SPECT (Single-Photon Emission Computed Tomography) Applications Market

7.3.3.1      Overview

7.3.3.2      Global SPECT (Single-Photon Emission Computed Tomography) Applications Market Revenue and  Forecasts to 2027 (US$ Mn)

7.3.4        PET (Positron Emission Tomography) Applications Market

7.3.4.1      Overview

7.3.4.2      Global PET (Positron Emission Tomography) Applications Market Revenue and Forecasts to 2027 (US$ Mn)


 

7.4       THERAPEUTIC APPLICATIONS Market

7.4.1        Overview

7.4.2        Global Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.3        Thyroid Market

7.4.3.1      Overview

7.4.3.2      Global Thyroid Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.4        Bone Metastasis Market

7.4.4.1      Overview

7.4.4.2      Global Bone Metastasis Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.5        Lymphoma Market

7.4.5.1      Overview

7.4.5.2      Global Lymphoma Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.6        Endocrine Tumors Market

7.4.6.1      Overview

7.4.6.2      Global Endocrine Tumors Market Revenue and Forecasts to 2027 (US$ Mn)

7.4.7        Other Therapeutic Applications Market

7.4.7.1      Overview

7.4.7.2      Global Other Therapeutic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

8.             global Nuclear Medicine/Radiopharmaceuticals Market analysis– by ENd User

8.1       overview

8.2       Global Nuclear Medicine/Radiopharmaceuticals Market, BY ENd User 2018 & 2027 (%)

8.3       hospitals market

8.3.1        Overview

8.3.2        Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Diagnostic Centers Market

8.4.1        Overview

8.4.2        Global Diagnostic Centers Market Revenue and Forecasts to 2025 (US$ Mn)

9.             Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 – geographical analysis

9.1       North America Nuclear Medicine/Radiopharmaceuticals market Revenue and Forecasts to 2027

9.1.1        North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2        North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.1.2.1      North America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.2.2      North America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.3        North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.4        North America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)

9.1.5        US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6        US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1      US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.1.6.1.1       US Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.6.1.2       US Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.6.2      US Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7        Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1      Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2      Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.1.7.2.1       Canada Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.2.2       Canada Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.3      Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.1.7.4      Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.5      Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.6      Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.1.7.6.1       Mexico Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.6.2       Mexico Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.7      Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2       Europe Nuclear Medicine/Radiopharmaceuticals market Revenue and Forecasts to 2027

9.2.1        Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.2        Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.2.1      Europe Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.2.2      Europe Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.3        Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.4        Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)

9.2.5        UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.1      UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.2      UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.5.2.1       UK Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.5.2.2       UK Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.5.3      UK Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.6        Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1      Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2      Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.6.2.1       Germany Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.6.2.2       Germany Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.6.3      Germany Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.7        France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1      France Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2      France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.7.2.1       France Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.7.2.2       France Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.7.3      France Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.8        Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1      Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2      Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.8.2.1       Italy Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.8.2.2       Italy Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.8.3      Italy Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.2.9        Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1      Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2      Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.2.9.2.1       Spain Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.9.2.2       Spain Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.9.3      Spain Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3       Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027

9.3.1        Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.2        Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.2.1      Asia Pacific Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.2.2      Asia Pacific Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.3        Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.4        Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027, By Country (%)

9.3.5        Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5.1      Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.5.2      Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.5.2.1       Japan Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.5.2.2       Japan Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.5.3      Japan Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.6        China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.1      China Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.6.2      China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.6.2.1       China Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.6.2.2       China Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.6.3      China Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7        India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.1      India Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.2      India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.7.2.1       India Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.7.2.2       India Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.7.3      India Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.7.4      South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.5      South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.7.6      South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.7.6.1       South Korea Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.7.6.2       South Korea Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.7.7      South Korea Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.3.8        Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.1      Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.3.8.2      Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.3.8.2.1       Australia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.8.2.2       Australia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.3.8.3      Australia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.4       Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027

9.4.1        Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.4.2        Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.4.2.1      Middle East & Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.4.2.2      Middle East & Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5       Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By End User (US$ Mn)

9.5.1        Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027,  By Country (%)

9.5.2        UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.2.1      UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.2.2      UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.5.2.2.1       UAE Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.2.2.2       UAE Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.2.3      UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.3        Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3.1      Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.3.2      Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.5.3.2.1       Saudi Arabia Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.3.2.2       Saudi Arabia Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.3.3      Saudi Arabia Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.5.4        South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.4.1      South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5.4.2      South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.5.4.2.1       South Africa Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.4.2.2       South Africa Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.5.4.3      South Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.6       South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027

9.6.1        South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027  (US$ Mn)

9.6.2        South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By Applications (US$ Mn)

9.6.2.1      South and Central America Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.2.2      South and Central America Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.3        South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.6.4        South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027,  By Country (%)

9.6.5        Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.5.1      Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.5.2      Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.6.5.2.1       Argentina Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.5.2.2       Argentina Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.5.3      Argentina Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

9.6.6        Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.6.1      Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

9.6.6.2      Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Applications (US$ Mn)

9.6.6.2.1       Brazil Diagnostic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.6.2.2       Brazil Therapeutic Applications Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.6.6.3      Brazil Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.          Nuclear Medicine/Radiopharmaceuticals Market– Industry Landscape

10.1    Overview

10.2    Comparative Company Analysis

10.3    Growth Strategies done by the companies in the Market, (%)

10.4    Organic Developments

10.4.1     Overview

10.5    Inorganic developments

10.5.1     Overview

11.          Nuclear Medicine/Radiopharmaceuticals Market–Key company profiles

11.1    Cardinal Health

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Financial Information

11.1.4     Product Portfolio

11.1.5     Swot Analysis

11.1.6     Key Developments

11.2    GENERAL ELECTRIC

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Financial Overview

11.2.4     Product Portfolio

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3    IBA Worldwide

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Financial Overview

11.3.4     Product Portfolio

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4    Curium

11.4.1     Key Facts

11.4.2     Business Description

11.4.1     Financial Information

11.4.2     Product Portfolio

11.4.3     SWOT Analysis

11.4.4     Key Developments

11.5    Positron Corporation

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Financial Overview

11.5.4     Product Portfolio

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6    Lantheus Medical Imaging, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Financial Information

11.6.4     Product Portfolio

11.6.5     Product Pipeline

11.6.6     SWOT Analysis

11.6.7     Key Developments

11.7    NTP Radioisotopes SOC Ltd (Necsa)

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Financial Overview

11.7.4     Product Portfolio

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8    BAYER AG

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Financial Overview

11.8.4     Product Portfolio

11.8.5     Product Pipeline

11.8.6     SWOT Analysis

11.8.7     Key Developments

11.9    Bracco

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Financial Overview

11.9.4     Product Portfolio

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10 Advanced Accelerator Applications (Novartis AG)

11.10.1   Key Facts

11.10.2   Business Description

11.10.3   Financial Overview

11.10.4   Product Portfolio

11.10.5   Product Pipeline

11.10.6   SWOT Analysis

11.10.7   Key Developments

12.          Appendix

12.1    About The Insight Partners

12.2    Glossary of Terms


list of tables

TABLE 1.           Principal radionuclides used in diagnostic Nuclear Medicine/Radiopharmaceuticals

TABLE 2.           North america Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By applications (US$ Mn)

TABLE 3.           North America Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 4.           North America Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 5.           North America Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 6.           US Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 7.           US Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8.           US Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 9.           US Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 10.        Canada Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 11.        Canada Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 12.        Canada Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 13.        Canada Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 14.        Mexico Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 15.        Mexico Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 16.        Mexico Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 17.        Mexico Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 18.        Europe Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 19.        Europe Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 20.        Europe Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 21.        Europe Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 22.        UK Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By applications (US$ Mn)

TABLE 23.        UK Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 24.        UK Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 25.        UK Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 26.        GERMANY Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications  (US$ Mn)

TABLE 27.        GERMANY Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 28.        GERMANY Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 29.        GERMANY Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 30.        FRANCE Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 31.        FRANCE Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 32.        FRANCE Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 33.        FRANCE Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 34.        ITALY Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 35.        ITALY Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 36.        ITALY Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 37.        ITALY Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 38.        SPAIN Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 39.        SPAIN Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 40.        SPAIN Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 41.        SPAIN Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 42.        ASIA PACIFIC Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications  (US$ Mn)

TABLE 43.        ASIA PACIFIC Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 44.        ASIA PACIFIC Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 45.        ASIA PACIFIC Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 46.        JAPAN Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 47.        JAPAN Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 48.        JAPAN Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 49.        JAPAN Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 50.        CHINA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 51.        CHINA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 52.        CHINA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 53.        CHINA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 54.        INDIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 55.        INDIA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 56.        INDIA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 57.        INDIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 58.        SOUTH KOREA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 59.        SOUTH KOREA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 60.        SOUTH KOREA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 61.        SOUTH KOREA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 62.        AUSTRALIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications  (US$ Mn)

TABLE 63.        AUSTRALIA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 64.        AUSTRALIA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 65.        AUSTRALIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 66.        MIDDLE EAST & AFRICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By applications (US$ Mn)

TABLE 67.        MIDDLE EAST & AFRICA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 68.        MIDDLE EAST & AFRICA Therapeutic Applications market Revenue And Forecasts to 2027,  By Type (US$ Mn)

TABLE 69.        MIDDLE EAST & AFRICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By end user (US$ Mn)

TABLE 70.        UAE Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 71.        UAE Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 72.        UAE Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 73.        UAE Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 74.        SAUDI ARABIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 75.        SAUDI ARABIA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 76.        SAUDI ARABIA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 77.        SAUDI ARABIA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 78.        SOUTH AFRICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 79.        SOUTH AFRICA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 80.        SOUTH AFRICA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 81.        SOUTH AFRICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user  (US$ Mn)

TABLE 82.        SOUTH AND CENTRAL AMERICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By applications (US$ Mn)

TABLE 83.        SOUTH AND CENTRAL AMERICA Diagnostic Applications market Revenue And Forecasts to 2027,  By Type (US$ Mn)

TABLE 84.        SOUTH AND CENTRAL AMERICA Therapeutic Applications market Revenue And Forecasts to 2027,  By Type (US$ Mn)

TABLE 85.        SOUTH AND CENTRAL AMERICA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027,  By end user (US$ Mn)

TABLE 86.        ARGENTINA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications  (US$ Mn)

TABLE 87.        ARGENTINA Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 88.        ARGENTINA Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 89.        ARGENTINA Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 90.        BRAZIL Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By applications (US$ Mn)

TABLE 91.        BRAZIL Diagnostic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 92.        BRAZIL Therapeutic Applications market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 93.        BRAZIL Nuclear Medicine/Radiopharmaceuticals market Revenue And Forecasts to 2027, By end user (US$ Mn)

TABLE 94.        Organic Developments Done By Companies

TABLE 95.        Inorganic developments done by Companies

TABLE 96.        Glossary of Terms, Nuclear Medicine/Radiopharmaceuticals market

 

list of figures

FIGURE 1.        NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SEGMENTATION

FIGURE 2.        Nuclear Medicine/Radiopharmaceuticals Segmentation, by region

FIGURE 3.        Asia Pacific Nuclear Medicine/Radiopharmaceuticals market, Revenue (US$ Mn), By Geography  2018 & 2027

FIGURE 4.        Global Nuclear Medicine/Radiopharmaceuticals Market By applications Market Share (%), 2018

FIGURE 5.        Global Nuclear Medicine/Radiopharmaceuticals Market By END USER, Market Share (%), 2018

FIGURE 6.        North America : PEST Analysis

FIGURE 7.        Europe : PEST Analysis

FIGURE 8.        Asia - Pacific : PEST Analysis

FIGURE 9.        Middle East & Africa : PEST Analysis

FIGURE 10.     South & Central America : PEST Analysis

FIGURE 11.     Nuclear Medicine/Radiopharmaceuticals market impact analysis of drivers and REstraints

FIGURE 12.     global Nuclear Medicine/Radiopharmaceuticals market – Revenue Forecasts and Analysis – 2019- 2027

FIGURE 13.     global Nuclear Medicine/Radiopharmaceuticals market – by geography Forecasts and Analysis – 2019- 2027

FIGURE 14.     MArket positioning of key player in global Nuclear Medicine/Radiopharmaceuticals market

FIGURE 15.     Global Nuclear Medicine/Radiopharmaceuticals Market, by applications 2018 & 2027 (%)

FIGURE 16.     Global Diagnostic Applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.     Global SPECT (single-photon emission computed tomography) applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.     Global PET (positron emission tomography) applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.     Global therapeutic applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 20.     Global thyroid Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.     Global bone metastasis Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.     Global lymphoma Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.     Global endocrine tumors Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 24.     Global other therapeutic applications Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.     global Nuclear Medicine/Radiopharmaceuticals Market, by ENd User 2018 & 2027 (%)

FIGURE 26.     global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 27.     global diagnostic centers Market Revenue and Forecasts to 2025 (US$ Mn)

FIGURE 28.     North america Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 29.     North america Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.     North America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 31.     US Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.     Canada Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 33.     Mexico Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 34.     Europe Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 35.     Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.     Europe Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027, By Country (%)

FIGURE 37.     UK Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38.     GERMANY Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39.     FRANCE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 40.     ITALY Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 41.     SPAIN Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 42.     Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018 (US$ MN)

FIGURE 43.     Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44.     Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 45.     JAPAN Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.     CHINA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.     INDIA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 48.     SOUTH KOREA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 49.     AUSTRALIA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 50.     Middle East & AFrica Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country, 2018  (US$ MN)

FIGURE 51.     Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.     Middle East & Africa Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 53.     UAE Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 54.     SAUDI ARABIA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 55.     SOUTH AFRICA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 56.     South and Central America Nuclear Medicine/Radiopharmaceuticals Market REVENUE, by Country,  2018 (US$ MN)

FIGURE 57.     South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027  (US$ Mn)

FIGURE 58.     South and Central America Nuclear Medicine/Radiopharmaceuticals Market Revenue And Forecasts to 2027,  By Country (%)

FIGURE 59.     ARGENTINA Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 60.     BRAZIL Nuclear Medicine/Radiopharmaceuticals Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 61.     Comparative Company Analysis

FIGURE 62.     Growth Strategies done by the companies in the Market, (%)


The List of Companies

  1. Cardinal Health
  2. IBA Worldwide
  3. Curium
  4. GENERAL ELECTRIC
  5. Bayer AG
  6. Positron Corporation
  7. NTP Radioisotopes SOC Ltd.
  8. Bracco
  9. Lantheus Medical Imaging Inc.
  10. Advanced Accelerator Applications
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550